-
Large Trial Testing Covid-19 Antibody Therapies
A clinical trial conducted by National Institutes of Health is evaluating two more synthetic antibodies as treatments for patients hospitalized with Covid-19 infections.
-
Fitness, Phone Data Captured for Heart Health Project
A digital health company is partnering with a cardiologist group to capture data from smartphones and wearable devices to provide users personalized heart health information.
-
Neuroscience Biotech Acquired in $770M Deal
A three year-old biotechnology company developing treatments for psychiatric and movement disorders is being acquired by global drug maker Novartis.
-
Gates Funding Home-Based Crispr Covid-19 Diagnostic
A medical device developer is receiving a Gates Foundation grant for a simple test to detect Covid-19 infections, done completely at home.
-
Trial Testing Ultrasound, Chemo for Brain Tumors
A clinical trial is underway assessing an implanted ultrasound device with chemotherapy to treat glioblastoma, an aggressive form of brain cancer.
-
ALS Stem Cell Treatments Found Safe, Slow Progression
Results from an early clinical trial of stem cells to treat amyotrophic lateral sclerosis, or ALS, shows the therapy is safe and slows progression of the disease.
-
AbbVie Acquires Coronavirus Antibody Therapy
Drug maker AbbVie is licensing a synthetic antibody to treat Covid-19 and SARS coronaviruses that the company began funding in June.
-
Biotech Licenses Precision Cancer Biologic to Genentech
A biotechnology company discovering synthetic proteins that target cancer-causing genetic mutations is licensing its lead product to biologics maker Genentech.
-
Financial Asset Managers Supporting Net Zero Emissions
Thirty asset managers, directing investments worth some $9 trillion, agreed to encourage their clients to achieve global net zero greenhouse gas emission goals.
-
New Business Enterprises to Consider in 2021
In a world that is constantly developing, and with very marked globalization, businesses have needed to expand or stagnate.